Skip to main content

and
  1. No Access

    Article

    Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

    We treated 17 patients with refractory (n=7) or relapsed lymphoid malignancy (n=10) following allogeneic HSCT with donor lymphocyte infusions (DLI). Patients with low-grade disease received DLI alone (n=7) or fol...

    N H Russell, J L Byrne, R D Faulkner, M Gilyead in Bone Marrow Transplantation (2005)